Philadelphia
Amicus Therapeutics is creating the Global Research and Gene Therapy Center of Excellence in Philadelphia. The 75,000-sf facility will provide collaborative laboratories and offices for the discovery and development of treatments for rare metabolic diseases. Accommodating up to 200 employees, the center will serve as the headquarters for the global Amicus science organization and the gene therapy division’s leadership team. Occupancy is expected in the second half of 2019. The project is located at uCity Square, a mixed-use knowledge community offering 6.5 million square feet of office, laboratory, clinical, residential, and retail facilities.
Source
